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Background
Exhaled nitric oxide (FENO) is a biomarker for eosino-
philic airway inflammation [1]. Elevated FENO has
been proposed as a marker for diagnosing asthma and
predicting asthma exacerbations [2]. We wished to
examine the association between known asthma risk
factors and FENO. A sub cohort of children (n=222)
participating in the Canadian Healthy Infant Longitu-
dinal Development (CHILD) study underwent infant
pulmonary function tests (IPFTs) during the first year
of life.
Methods
Risk factors were obtained from a subset of available
CHILD questionnaires administered prenatally and
3 times during the first year of life. FENO was collected
using a multiple-breath sampling technique during quiet
tidal breathing at the 3 month visit, 1 year visit, or both
visits. Prenatal smoke exposure was defined as any
maternal smoking, including mothers who stopped or
cut down on smoking during pregnancy. Postnatal
smoke exposure was defined as any exposure in or away
from the home up to 1 year of age. Parental asthma was
defined as self-reported or doctor diagnosed asthma.
Parental atopic status was confirmed by allergy skin
tests. T-tests with Bonferroni correction for multiple
comparisons were used to compare FENO in the exposed
and unexposed groups (a=0.004).
Results
At the 3 month visit, 134 infants attended the IPFT
lab, and 84 of 117 attempted eNO tests were success-
fully analyzed; mean FENO was 16.8±8.1ppb. At the 1
year visit, 181 infants attended the IPFT lab and 138
of 158 attempted eNO tests were successfully analyzed;
mean FENO was 15.3±9.7ppb. Prenatal smoking rates
were low (3% and 6%) and showed no association with
FENO (Table 1). Postnatal smoke exposure was also
not associated with FENO. FENO was not statistically
different in infants whose mothers or fathers had
a history of asthma or atopic status, compared to
those without. Having siblings was not significantly
associated with FENO after applying the Bonferroni
correction.
Conclusions
Smoke exposure was not related to FENO, however no
nicotine biomarker was assessed and smoking rates were
low. Maternal and paternal histories were not associated
with FENO levels in healthy children up to 1 year of age.
None of the risk factors were statistically significantly
associated with FENO, however infants with siblings
were observed to have a lower FENO than infants with-
out siblings at the 1 year visit. A larger sample size is
required to increase the power of these tests. Further
factors must be studied to explain the variation in FENO
measures seen.
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Table 1
Variable Testing Time Point Sample Size Mean ± SD (ppb) P value
Prenatal Smoke Exposure 3 months Yes 2 13.12 ± 0.8 0.072
No 57 15.40 ± 7.7
1 Year Yes 6 21.12 ± 14.6 0.405
No 100 15.63 ± 9.5
Postnatal Smoke Exposure 3 months Yes 14 15.13 ± 7.5 0.471
No 64 16.76 ± 7.6
1 Year Yes 38 13.72 ± 8.2 0.233
No 99 15.73 ± 10.1
Maternal Atopic Status 3 months Yes 47 16.72 ± 7.5 0.458
No 19 15.19 ± 7.5
1 Year Yes 87 15.11 ± 10.0 0.638
No 40 15.94 ± 8.9
Maternal Asthma 3 months Yes 16 17.23 ± 8.2 0.495
No 49 15.62 ± 7.5
1 Year Yes 29 14.50 ± 7.9 0.460
No 88 15.86 ± 10.3
Paternal Atopic Status 3 months Yes 55 16.32 ± 7.4 0.925
No 12 16.07 ± 8.4
1 Year Yes 87 15.13 ± 9.4 0.085
No 21 19.24 ± 9.5
Paternal Asthma 3 months Yes 10 15.45 ± 10.0 0.962
No 48 15.28 ± 7.2
1 Year Yes 20 19.42 ± 10.1 0.081
No 80 14.89 ± 9.5
Sibling 3 months Yes 30 13.54 ± 8.2 0.065
No 29 17.17 ± 6.5
1 Year Yes 46 13.27 ± 10.0 0.015
No 60 17.98 ± 9.4
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